Back to Blog
MagVenture TMS therapy ProvoFebruary 28, 2026

What Is MagVenture TMS Therapy?

Isaac ToleafoaIsaac Toleafoa · Founder
What Is MagVenture TMS Therapy?: realistic RSLNT Wellness image for MagVenture TMS therapy Provo.

If you're considering MagVenture TMS therapy Provo, it helps to know what treatment actually involves day to day. This guide explains how TMS works, what sessions feel like, who may be a fit, and what to expect during care at our Provo clinic. Keep reading for the practical details, or reach out if you'd rather talk through your options with our team.

When people search for MagVenture TMS therapy Provo, the real questions underneath are usually practical: will it hurt, will it fit into my life, and what do I do if medication has already let me down?

What MagVenture TMS actually is, in plain language

A MagVenture TMS setup is not just a generic chair. The patient sits in a MagVenture motorized procedure chair while a trained TMS technician positions the Cool B70 butterfly coil against a mapped treatment location on the scalp. The coil is held steady by the Flow Arm and powered by the MagPro R30 stimulator.

The coil sends short magnetic pulses, similar in strength to an MRI machine, into a specific spot, the dorsolateral prefrontal cortex. That spot matters because depression researchers have shown for decades that this region is often underactive in patients with major depression. The pulses don't add a chemical. They don't sedate you. They don't cross any blood-brain barrier. They prompt the brain's own circuitry to fire, repeatedly, until the underactive region wakes up.

Repeat that over weeks and the brain's neuroplasticity, the same mechanism that lets you learn a new language or recover from a stroke, builds new connections in the parts of the brain that handle mood and motivation.

It sounds like science fiction. It's not. It's standard psychiatric care now, and MagVenture is the platform RSLNT chose for that care.

That is the plain-language answer. The clinical answer is that repetitive stimulation changes how networks involved in mood, rumination, drive, and attention communicate with each other. Patients usually do not feel that biology happening in real time. What they notice is more ordinary and more important: getting out of bed takes less negotiation, simple tasks stop feeling impossible, and the day stops feeling quite so heavy.

What a MagVenture session feels like

Most patients describe the sensation as a woodpecker tapping on the side of a hard hat. Not painful. Slightly uncomfortable in the first few sessions while your scalp adjusts.

You sit in the MagVenture motorized procedure chair. The technician positions the Cool B70 coil with the Flow Arm. The pulses run in short bursts for around 19 minutes, depending on the protocol your clinician orders. You can read. You can scroll your phone. You can text your spouse. Some patients close their eyes and rest.

When the timer ends, you stand up, walk out, and drive yourself home. There's no anesthesia, no needles, no recovery time, and no driving restriction.

The first few visits are usually the most noticeable because your scalp and forehead muscles are not used to the tapping. If the sensation is too sharp, we do not just tell you to tolerate it. We check coil position, make small adjustments, and help you settle into the chair correctly. By the end of week one, most patients know exactly what to expect and stop bracing for the session.

Why we lead with MagVenture

RSLNT chose MagVenture because the equipment matters to the patient experience. Our setup uses the MagVenture TMS Therapy System R30 with Express TMS, the Cool B70 butterfly coil, the MagPro R30 stimulator, and MagVenture's motorized procedure chair. That is the actual chair and device platform patients see in our Provo clinic.

The FDA history is important, but it needs to be said precisely. Tonica/MagVenture had an FDA 510(k) clearance for the MagPro R30 magnetic stimulator in 2006. That earlier clearance was for peripheral nerve stimulation for diagnostic purposes, not depression treatment. The depression-specific rTMS classification came through a different manufacturer's 2008 de novo/510(k) pathway. MagVita/MagVenture then received FDA clearance for major depressive disorder in 2015 and has continued expanding its cleared TMS indications.

So if you hear that MagVenture came first, that is true for MagVenture's magnetic-stimulation device lineage. If you hear that the first depression-specific FDA pathway came later through another TMS system, that is also true. What matters for RSLNT patients is this: we use MagVenture now, and MagVenture's current FDA-cleared TMS indications include major depressive disorder, MDD with comorbid anxiety symptoms in adults, adjunct treatment for OCD, and adjunct treatment for adolescent MDD in specific patient groups.

The American Psychiatric Association lists TMS as a recommended treatment for treatment-resistant major depressive disorder, with strong evidence supporting its use after two failed antidepressant trials.

What treatment looks like start to finish

Standard treatment is 36 sessions over about 6 weeks.

  • Day 1: Motor threshold mapping. The clinician finds the exact spot on your skull above your motor cortex by giving small pulses until your thumb twitches. This calibrates the device to your specific brain. Around 45 minutes total.
  • Days 2 through 20: Daily 19-minute sessions, Monday through Friday for 4 weeks.
  • Weeks 5 and 6: Tapered sessions, going from daily to less frequent over two weeks.

Some patients add a maintenance session every 6 to 12 months once they respond.

Before day one, there is a real clinical review. Depression that has not improved is not automatically the same thing as treatment-resistant depression. We make sure we are not missing bipolar symptoms, active substance withdrawal, a seizure risk issue, or another medical or psychiatric problem that changes the plan.

The calendar piece matters too. TMS works best when patients are consistent. If you miss a day because of illness, travel, or a family emergency, we usually resume and keep moving. Most people fit treatment into ordinary life the same way they would physical therapy or follow-up medical care: before work, after school drop-off, or over a lunch break.

What side effects and safety look like in real life

The most common side effects are simple: scalp tenderness, a mild headache, jaw or forehead muscle twitching during treatment, and fatigue for a small number of patients. Most of that is front-loaded. The first week is usually the adjustment week. After that, sessions tend to feel routine.

The rare risk everyone asks about is seizure. That risk is low, but this is exactly why screening matters. We ask about seizure history, head injuries, metal near the skull, stimulant use, sleep deprivation, alcohol or benzodiazepine withdrawal, and anything else that changes safety. TMS is safe when it is done carefully. It is not something to treat casually.

There is also a practical detail people do not think about until they are in the chair: the clicking is loud. Ear protection is standard. A well-run TMS clinic pays attention to those small details because they change whether patients can stay consistent for the full course.

Who TMS is and isn't for

Strong fits:

  • Patients with major depressive disorder who haven't responded to two or more antidepressants
  • Patients who can't tolerate antidepressant side effects
  • Patients with OCD who haven't responded to SSRIs alone
  • Patients in recovery from substance use who want a drug-free option
  • Veterans on heavy medication stacks

Not a fit:

  • Patients with metal implants in or near the head, including aneurysm clips, cochlear implants, or deep-brain stimulators (a pacemaker doesn't disqualify you, but disclosure matters)
  • Patients with seizure disorders or active substance withdrawal
  • Children under 18 (off-label clinical trials only)
  • Patients who haven't yet tried a first-line antidepressant or therapy (we'd usually start there)

We screen for all of this in the first consultation.

A patient does not have to be bedridden to qualify. Some of the best candidates are still showing up to work, still parenting, still functioning on paper, but doing it with flat mood, poor motivation, and an amount of effort that is no longer sustainable.

What the research shows for Provo, Utah, and beyond

The largest meta-analyses on TMS for depression, including data from the National Institute of Mental Health and Stanford-led studies, show response rates of 50 to 65 percent and remission rates of 30 to 40 percent in patients with treatment-resistant depression. Real-world clinic numbers from established TMS centers are often slightly higher, in the 60 to 65 percent response range.

For comparison, antidepressant response rates after two prior failures drop to roughly 14 to 25 percent, per the STAR*D trial. For Provo and Utah County patients who have already tried two or three medications, TMS gives meaningfully better odds.

The other clinically important point is durability. A good TMS response is not a one-day lift that disappears the next morning. Many patients hold onto improvement after the acute course ends, and some return later for booster treatment if symptoms creep back. That is not failure. That is long-term depression care being managed like a long-term illness.

What improvement usually looks like week by week

The first changes are usually not dramatic. Patients often tell us they still feel depressed, but they notice a few things have shifted: they are answering texts, getting through the morning with less dread, or finishing tasks they had been circling for weeks. Concentration can improve before mood fully improves. Irritability can calm down before motivation returns.

Sometimes family notices it first. The patient is speaking more, leaving the bedroom more, or engaging in therapy instead of just enduring it. That is what real response often looks like in clinic. Not euphoria. Not a personality transplant. Just a steady return of initiative, emotional range, and the ability to use the coping tools they already had but could not access consistently.

How we actually treat this at RSLNT

At RSLNT Wellness, our Provo clinic is built around MagVenture TMS technology and a complete care model with all three pillars under one roof.

We also do not treat TMS like a vending machine. If someone comes in asking for magventure tms therapy provo because they are desperate, we slow the process down enough to make sure the story fits the treatment. The right patient can do very well with TMS. The wrong diagnosis does not become the right diagnosis because a device is available.

Counseling that pairs with TMS. Patients who do therapy alongside TMS often see more durable results. Our clinicians use cognitive behavioral therapy and acceptance and commitment therapy. We schedule therapy on the same day as TMS when it fits.

Medication management that coordinates with whatever you're already taking. SSRIs like sertraline and escitalopram, SNRIs like venlafaxine, bupropion when motivation is the issue. We don't push pills. We don't withhold them either.

TMS therapy with full insurance verification before you start. We handle the prior authorization with SelectHealth, Regence, Cigna, Aetna, United, Medicare, TRICARE, and VA Community Care. Most patients pay $0 to $1,800 out of pocket after coverage. We tell you the exact number before session one.

Frequently asked questions

Is TMS the same thing as ECT?

No. ECT (electroconvulsive therapy) is a different treatment that uses electrical currents under anesthesia to induce a brief seizure. ECT is highly effective for severe, life-threatening depression, but it requires anesthesia and has cognitive side effects. TMS uses magnetic fields, no anesthesia, no seizure, and no cognitive side effects.

How fast does TMS work?

Some patients feel a small lift in week 2. The bigger shift typically lands between weeks 3 and 5. By the end of the six-week course, most patients see a meaningful drop in their depression scores. The first changes are often subtle: less dread in the morning, better follow-through, or a little more emotional range before mood fully catches up.

What if it doesn't work?

About 35 to 40 percent of patients don't fully respond to a first TMS course. We have several next moves: extending the course, adjusting the target site, switching to an accelerated protocol like SAINT, returning to a different medication, or referring for ECT in severe cases. We don't drop you when one path doesn't work.

Does insurance usually cover TMS?

Often, yes, but coverage depends on your plan and your treatment history. Most insurers want documentation that depression has not improved with prior treatment, usually medication and sometimes therapy. We verify benefits and handle prior authorization before treatment starts so you know the financial answer before session one.

Ready to feel like yourself again?

Schedule a free consultation to see if TMS therapy is right for you.

Book Your Consultation